BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27578584)

  • 1. [(18)F-FDG PET/CT for extranodular natural killer/T-cell lymphoma nasal type: imaging findings and clinical value].
    Song JH; Qiao WL; Chen X; Liu CC; Xing Y; Wang TS; Zhao JH
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Aug; 36(8):1123-8. PubMed ID: 27578584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pretreatment evaluation of
    Peng P; Wu N; Tao XL; Liu Y; Lyu L; Cheng X
    Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):370-376. PubMed ID: 35448927
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
    Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS
    Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the prognostic capacity of pretreatment, interim, and post-therapy (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma, nasal type.
    Jiang C; Zhang X; Jiang M; Zou L; Su M; Kosik RO; Tian R
    Ann Nucl Med; 2015 Jun; 29(5):442-51. PubMed ID: 25801633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of 18F-FDG PET/CT for cutaneous extranodal natural killer/T-cell lymphoma, nasal type.
    Liu C; Zhang Y; Zhang Y; Wang M; Liu R; Liu X; Hu S
    Nucl Med Commun; 2016 May; 37(5):446-52. PubMed ID: 26657218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of Pretherapeutic
    Ding CY; Liu HY; Guo Z; Li TN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):438-443. PubMed ID: 28446289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods.
    Moon SH; Cho SK; Kim WS; Kim SJ; Chan Ahn Y; Choe YS; Lee KH; Kim BT; Choi JY
    J Nucl Med; 2013 Jul; 54(7):1039-44. PubMed ID: 23658217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of positron emission tomography/computed tomography in the staging of extranodal natural killer/T-cell lymphoma.
    Fujiwara H; Maeda Y; Nawa Y; Yamakura M; Ennishi D; Miyazaki Y; Shinagawa K; Hara M; Matsue K; Tanimoto M
    Eur J Haematol; 2011 Aug; 87(2):123-9. PubMed ID: 21557776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of
    Geng H; Li J; Zhang W
    Heliyon; 2024 Jan; 10(1):e23922. PubMed ID: 38226231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the lymph nodes: FDG-PET/CT in primary extranodal lymphoma.
    Sin KM; Ho SK; Wong BY; Gill H; Khong PL; Lee EY
    Clin Imaging; 2017; 42():25-33. PubMed ID: 27875758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Application Value of True Whole-body PET/CT Scanning Protocol in Patients of Extranodal NK/T Cell Lymphoma].
    Li FL; Su MG; Shi DZ; Liang FL; Li L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 51(2):245-251. PubMed ID: 32220195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    Ding CY; Li H; Liu C; Li X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1047-1052. PubMed ID: 28823266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of 18F-FDG PET/CT for staging NK/T-cell lymphomas.
    Wu HB; Wang QS; Wang MF; Li HS; Zhou WL; Ye XH; Wang QY
    Nucl Med Commun; 2010 Mar; 31(3):195-200. PubMed ID: 20009963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of baseline, interim and end-of-treatment
    Chang Y; Fu X; Sun Z; Xie X; Wang R; Li Z; Zhang X; Sheng G; Zhang M
    Sci Rep; 2017 Jan; 7():41057. PubMed ID: 28117395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma of Lower Limb Muscles on 18 F-FDG PET/CT.
    Li C; Hu X
    Clin Nucl Med; 2024 Jan; 49(1):e45-e46. PubMed ID: 37976527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activity of extranodal NK/T cell lymphoma on
    Lim CH; Yoon SE; Kim SJ; Cho J; Ko YH; Lee KH; Kim WS
    Sci Rep; 2021 Mar; 11(1):5879. PubMed ID: 33723329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of nasal type NK/T cell lymphoma presenting as neurolymphomatosis on 18F-FDG PET/CT: A case report and literature review.
    Pan Q; Luo Y
    Medicine (Baltimore); 2020 Jan; 99(1):e18640. PubMed ID: 31895825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extranodal NK/T-Cell Lymphoma With Widespread Cutaneous and Subcutaneous Involvement on 18 F-FDG PET/CT.
    Filizoglu N; Ozguven S; Ones T; Turoglu HT; Erdil TY
    Clin Nucl Med; 2022 Oct; 47(10):e630-e631. PubMed ID: 35383610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriate timing to perform an interim
    Wang R; Zhang Y; Fan Q; Jiang M; Zou L; Su M
    Ann Hematol; 2024 Mar; 103(3):885-892. PubMed ID: 38030892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma.
    Karantanis D; Subramaniam RM; Peller PJ; Lowe VJ; Durski JM; Collins DA; Georgiou E; Ansell SM; Wiseman GA
    Clin Lymphoma Myeloma; 2008 Apr; 8(2):94-9. PubMed ID: 18501102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.